Concourse Financial Group Securities’s Syndax Pharmaceuticals SNDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Hold |
0
| – | – | – | 7127 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 7621 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 7612 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 7623 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 7626 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 7557 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 7378 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 7199 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 6943 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 6955 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 6776 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 6707 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 6583 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 6505 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 6299 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 6081 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 5871 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 5697 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 5481 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 5345 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 5291 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 5215 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 5038 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 5131 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 5057 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 4945 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 4748 |
|